The global surgical sutures market was valued at approximately USD 5.02 billion in 2025 and projected to reach USD 6.46 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period. Market growth is fueled by increasing surgical procedures globally and innovations in suture materials, including smart and antibacterial sutures.
Enhancements in global healthcare infrastructure elevate demand for effective wound closure solutions. The rising prevalence of chronic wounds, notably diabetic foot ulcers affecting 6.3% of diabetic adults worldwide, significantly contributes to suture market expansion. Furthermore, the increasing incidence of road traffic accidents causing severe trauma necessitates reliable wound closure methods.
Annually, approximately 313 million surgeries occur worldwide, with an additional estimated 143 million procedures needed to address essential healthcare requirements in resource-limited regions. Common surgeries such as cataracts and orthopedic replacements rely on suturing for effective wound management, driving consistent demand.
The market demonstrates moderate growth momentum accelerated by advanced materials and medical technologies improving suture efficacy. Demographic shifts, including an aging population and chronic disease prevalence, further support market demand.
Consolidation through mergers and acquisitions is increasing, enabling firms to broaden portfolios and technology access, optimize operations, and expand distribution networks.
Regulatory frameworks established by agencies like the FDA and EMA enforce rigorous quality and safety standards for surgical sutures. Alternative wound closure solutions, including adhesive tissue sealants, staples, and hemostats, provide complementary options but traditional sutures remain dominant.
Collaborations and expansions via partnerships with local distributors and manufacturers enhance global market reach. Recent advances include development of nanosilver-coated silk sutures to reduce surgical site infections, addressing a significant share of healthcare-associated infections.
Absorbable sutures, comprising natural and synthetic polymers, dominated the market due to their tissue compatibility and self-degrading properties, eliminating the need for suture removal. In 2025, Corza Medical expanded its ophthalmic suture portfolio with both absorbable and non-absorbable options tailored for delicate surgeries.
Non-absorbable sutures are also expanding, attributed to their durable nature suitable for prolonged tissue support.
Multifilament sutures maintain the largest market revenue share due to superior flexibility and tensile strength. Monofilament sutures are gaining popularity due to reduced tissue trauma and lower infection risk, projected to experience the fastest growth.
General surgery is the largest application segment, with widespread use in diverse surgical interventions. Cardiovascular surgery is anticipated to register rapid growth due to increasing cardiac disease prevalence and supportive healthcare ecosystems.
| Attribute | Information |
|---|---|
| Market Size (2025) | USD 5.02 billion |
| Forecast Revenue (2030) | USD 6.46 billion |
| Growth Rate (CAGR) | 5.2% (2025–2030) |
| Historical Data | 2018–2023 |
| Forecast Period | 2025–2030 |
| Segments Included | Type, Filament, Application, Region |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Countries Included | U.S., Canada, UK, Germany, Italy, France, Spain, Sweden, Denmark, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Kuwait |
What was the market size for surgical sutures in 2025?
The market was valued at approximately USD 5.02 billion.
What is the expected CAGR between 2025 and 2030?
The market is projected to grow at 5.2% CAGR during this period.
Which suture type dominates the market?
Absorbable sutures hold the largest market share due to their biodegradability and patient convenience.
Which region leads the surgical sutures market?
North America holds the highest market share, driven by technological advances and healthcare investment.
What are the key recent innovations?
Developments include knotless all-suture anchors and advanced ophthalmic sutures for delicate surgeries.
Who are the major market players?
Medtronic, Stryker, Smith+Nephew, Ethicon, B. Braun, and Riverpoint Medical are among the top companies.
